增加安全医用大麻的可及性：在一家安全网学术医疗中心建立医用大麻项目。
Increasing Access to Safe Medical Cannabis: Establishment of a Medical Cannabis Program in a Safety-Net Academic Medical Center.
作者信息
Ross Jonathan, Yamada Jaclyn, Slawek Deepika, Starrels Joanna L, Cunningham Chinazo O, Arnsten Julia H
机构信息
Assistant Professor of Medicine, Montefiore Health System, Division of General Internal Medicine, Bronx, New York, USA.
Assistant Professor of Medicine, Albert Einstein College of Medicine, Division of General Internal Medicine, Bronx, New York, USA.
出版信息
NEJM Catal Innov Care Deliv. 2022 Feb;3(2). doi: 10.1056/cat.21.0373. Epub 2022 Jan 19.
Abstract
Despite numerous challenges, Montefiore Medical Center in New York City implemented a program aimed at providing comprehensive, evidence-based medical cannabis certifications to patients, including those who have been historically disenfranchised, and shares insights from five years of operation.
摘要
尽管面临诸多挑战，纽约市的蒙特菲奥里医疗中心实施了一项计划，旨在为患者提供全面的、基于证据的医用大麻认证，包括那些历史上被剥夺选举权的患者，并分享了五年运营中的见解。
相似文献
1
Increasing Access to Safe Medical Cannabis: Establishment of a Medical Cannabis Program in a Safety-Net Academic Medical Center.增加安全医用大麻的可及性：在一家安全网学术医疗中心建立医用大麻项目。
NEJM Catal Innov Care Deliv. 2022 Feb;3(2). doi: 10.1056/cat.21.0373. Epub 2022 Jan 19.
2
New York's role as a center for health care: an analysis of nonresident patients served by New York City hospitals.纽约作为医疗保健中心的角色：对纽约市医院服务的非本地患者的分析。
Pap Ser United Hosp Fund N Y. 1986 Oct(4):1-38.
3
Integrated Medical Cannabis Consultations in a Palliative Care Program: Policies, Procedures, and Progress after Six Years of Practice.姑息治疗项目中的综合医用大麻咨询：六年实践后的政策、程序与进展
J Palliat Med. 2022 May;25(5):802-806. doi: 10.1089/jpm.2021.0577. Epub 2022 Mar 18.
4
The establishment of the School of Public Health at the State University of New York, Downstate Medical Center: the first nationally accredited school of public health in a public university in New York City.纽约州立大学下州医学中心公共卫生学院的建立：纽约市公立大学中第一所获得国家认可的公共卫生学院。
J Community Health. 2011 Feb;36(1):1-13. doi: 10.1007/s10900-010-9330-x.
5
Regulating compassion: an overview of Canada's federal medical cannabis policy and practice.规范同情心：加拿大联邦医用大麻政策与实践概述。
Harm Reduct J. 2008 Jan 28;5:5. doi: 10.1186/1477-7517-5-5.
6
Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.医用大麻与阿片类药物（MEMO）研究：一项纵向队列研究方案，旨在观察医用大麻是否能减少慢性疼痛成年患者的阿片类药物使用量。
BMJ Open. 2020 Dec 29;10(12):e043400. doi: 10.1136/bmjopen-2020-043400.
7
Adaptation and restructuring of an academic anesthesiology department during the COVID-19 pandemic in New York City: Challenges and lessons learned.在纽约市 COVID-19 大流行期间对学术麻醉科的调整和重构：挑战与经验教训。
Best Pract Res Clin Anaesthesiol. 2021 Oct;35(3):425-435. doi: 10.1016/j.bpa.2020.12.010. Epub 2020 Dec 10.
8
First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort Study.使用阿片类药物治疗慢性疼痛的成年人中医用大麻的第一年使用轨迹：一项观察性队列研究。
Pain Med. 2021 Dec 11;22(12):3080-3088. doi: 10.1093/pm/pnab257.
9
Medical cannabis in supportive cancer care: lessons from Canada.支持性癌症护理中的医用大麻：来自加拿大的经验教训。
Support Care Cancer. 2020 Jul;28(7):2999-3001. doi: 10.1007/s00520-020-05403-2. Epub 2020 Mar 14.
10
Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada. dispensaries 是否不可或缺？加拿大从医用大麻药房获取大麻的患者体验。
Int J Drug Policy. 2017 Sep;47:1-8. doi: 10.1016/j.drugpo.2017.05.046. Epub 2017 Jun 28.
引用本文的文献
1
Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center.可及但不可及：在学术医疗中心的初级保健为基础的医疗大麻计划的头 2 年中患者的体验。
Harm Reduct J. 2024 Jan 2;21(1):1. doi: 10.1186/s12954-023-00919-2.
2
"It doesn't make any sense to even try": the disruptive impact of COVID-19's first wave on people with chronic pain using medical cannabis in New York.“甚至尝试都毫无意义”：新冠疫情第一波对纽约使用医用大麻的慢性疼痛患者的破坏性影响。
J Cannabis Res. 2023 Mar 29;5(1):10. doi: 10.1186/s42238-023-00180-1.
本文引用的文献
1
First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort Study.使用阿片类药物治疗慢性疼痛的成年人中医用大麻的第一年使用轨迹：一项观察性队列研究。
Pain Med. 2021 Dec 11;22(12):3080-3088. doi: 10.1093/pm/pnab257.
2
How medical are states' medical cannabis policies?: Proposing a standardized scale.各州的医用大麻政策有多“医学”？：提出一个标准化的评估尺度。
Int J Drug Policy. 2021 Aug;94:103202. doi: 10.1016/j.drugpo.2021.103202. Epub 2021 Mar 23.
3
Medical cannabis use in the United States: a retrospective database study.美国医用大麻的使用：一项回顾性数据库研究。
J Cannabis Res. 2020 Sep 29;2(1):32. doi: 10.1186/s42238-020-00038-w.
4
Medical Marijuana and Opioids (MEMO) Study: protocol of a longitudinal cohort study to examine if medical cannabis reduces opioid use among adults with chronic pain.医用大麻与阿片类药物（MEMO）研究：一项纵向队列研究方案，旨在观察医用大麻是否能减少慢性疼痛成年患者的阿片类药物使用量。
BMJ Open. 2020 Dec 29;10(12):e043400. doi: 10.1136/bmjopen-2020-043400.
5
Daily and near-daily cannabis use is associated with HIV viral load suppression in people living with HIV who use cocaine.每日或近日常规使用大麻与同时使用可卡因的 HIV 感染者的 HIV 病毒载量抑制有关。
AIDS Care. 2021 Oct;33(10):1350-1357. doi: 10.1080/09540121.2020.1799922. Epub 2020 Aug 4.
6
Racism and Its Effect on Cannabis Research.种族主义及其对大麻研究的影响。
Cannabis Cannabinoid Res. 2020 Feb 27;5(1):2-5. doi: 10.1089/can.2019.0063. eCollection 2020 Mar 1.
7
Medical Cannabis Use among Adults in the Southeastern United States.美国东南部成年人使用医用大麻的情况。
Cannabis. 2019 Feb 9;2(1):53-65.
8
Qualifying Conditions Of Medical Cannabis License Holders In The United States.美国医用大麻许可证持有者的资格条件。
Health Aff (Millwood). 2019 Feb;38(2):295-302. doi: 10.1377/hlthaff.2018.05266.
9
Examination of Market Segmentation among Medical Marijuana Dispensaries.医用大麻药房的市场细分研究
Subst Use Misuse. 2018 Jul 29;53(9):1463-1467. doi: 10.1080/10826084.2017.1413391. Epub 2018 Jan 5.
10
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep.用医用大麻替代用于止痛、抗焦虑和助眠的药物制剂。
J Psychopharmacol. 2017 May;31(5):569-575. doi: 10.1177/0269881117699616. Epub 2017 Apr 4.
Zotero 插件